albuterol has been researched along with Apnea, Sleep in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rasche, K | 1 |
| Duchna, HW | 1 |
| Orth, M | 1 |
| Bauer, TT | 1 |
| Lauer, J | 1 |
| Podbregar, D | 1 |
| Schultze-Werninghaus, G | 1 |
1 trial available for albuterol and Apnea, Sleep
| Article | Year |
|---|---|
[Effect of salmeterol in obstructive sleep apnea syndrome].
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double- | 1998 |